| TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ... Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013 | 1526 | 2013 |
| Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas Y Jiao, PJ Killela, ZJ Reitman, BA Rasheed, CM Heaphy, RF De Wilde, ... Oncotarget 3 (7), 709, 2012 | 683 | 2012 |
| Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism ZJ Reitman, H Yan Journal of the National Cancer Institute 102 (13), 932-941, 2010 | 619 | 2010 |
| Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome ZJ Reitman, G Jin, ED Karoly, I Spasojevic, J Yang, KW Kinzler, Y He, ... Proceedings of the National Academy of Sciences 108 (8), 3270-3275, 2011 | 481 | 2011 |
| Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas PJ Killela, CJ Pirozzi, P Healy, ZJ Reitman, E Lipp, BA Rasheed, R Yang, ... Oncotarget 5 (6), 1515, 2014 | 293 | 2014 |
| Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas L Zhang, LH Chen, H Wan, R Yang, Z Wang, J Feng, S Yang, S Jones, ... Nature genetics 46 (7), 726-730, 2014 | 181 | 2014 |
| Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas G Jin, ZJ Reitman, CG Duncan, I Spasojevic, DM Gooden, BA Rasheed, ... Cancer research 73 (2), 496-501, 2013 | 153 | 2013 |
| 2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP+-dependent isocitrate dehydrogenase mutations G Jin, ZJ Reitman, I Spasojevic, I Batinic-Haberle, J Yang, ... PloS one 6 (2), e16812, 2011 | 138 | 2011 |
| The genome-wide mutational landscape of pituitary adenomas ZJ Song, ZJ Reitman, ZY Ma, JH Chen, QL Zhang, XF Shou, CX Huang, ... Cell research 26 (11), 1255-1259, 2016 | 137 | 2016 |
| Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia ZJ Reitman, CG Duncan, E Poteet, A Winters, LJ Yan, DM Gooden, ... Journal of Biological Chemistry 289 (34), 23318-23328, 2014 | 101 | 2014 |
| IDH1 and IDH2: not your typical oncogenes ZJ Reitman, DW Parsons, H Yan Cancer cell 17 (3), 215-216, 2010 | 90 | 2010 |
| The genetic landscape of anaplastic astrocytoma PJ Killela, CJ Pirozzi, ZJ Reitman, S Jones, BA Rasheed, E Lipp, ... Oncotarget 5 (6), 1452, 2014 | 81 | 2014 |
| Exomic sequencing of four rare central nervous system tumor types C Bettegowda, N Agrawal, Y Jiao, Y Wang, LD Wood, FJ Rodriguez, ... Oncotarget 4 (4), 572, 2013 | 80 | 2013 |
| IDH1R132 mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain GY Lopez, ZJ Reitman, D Solomon, T Waldman, DD Bigner, ... Biochemical and biophysical research communications 398 (3), 585-587, 2010 | 78 | 2010 |
| Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells ZJ Reitman, BR Paolella, G Bergthold, K Pelton, S Becker, R Jones, ... Nature communications 10 (1), 3731, 2019 | 55 | 2019 |
| Picornavirus genome replication: identification of the surface of the poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg uridylylation and construction of a … M Shen, ZJ Reitman, Y Zhao, I Moustafa, Q Wang, JJ Arnold, HB Pathak, ... Journal of biological chemistry 283 (2), 875-888, 2008 | 50 | 2008 |
| New directions in the treatment of glioblastoma ZJ Reitman, F Winkler, AEH Elia Seminars in neurology 38 (01), 050-061, 2018 | 43 | 2018 |
| IDH1 and IDH2 hotspot mutations are not found in canine glioma ZJ Reitman, NJ Olby, CL Mariani, R Thomas, M Breen, DD Bigner, ... International journal of cancer. Journal international du cancer 127 (1), 245, 2010 | 37 | 2010 |
| Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila ZJ Reitman, SA Sinenko, EP Spana, H Yan Blood, The Journal of the American Society of Hematology 125 (2), 336-345, 2015 | 33 | 2015 |
| Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition JT Low, V Chandramohan, ML Bowie, MC Brown, MS Waitkus, A Briley, ... Cancer Cell 40 (5), 439-440, 2022 | 29 | 2022 |
